Camlin Fine Sciences Ltd

Camlin Fine Sciences Limited informed the BSE Limited and National Stock Exchange of India Ltd that it received a confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026, from MUFG Intime India Private Limited, formerly Link Intime India Private Limited, its Registrar and Share Transfer Agent.

Camlin Fine Sciences Limited will close its trading window for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, in compliance with SEBI regulations.

Camlin Fine Sciences Limited announced that its Board of Directors approved the appointment of Mr. Atul Pradhan (DIN: 00171022) as an Additional Non-Executive Independent Director for a term of five years, effective September 11, 2026, subject to shareholder approval. Mr. Pradhan is an IICA-certified Independent Director and former Head of Management Consulting at KPMG India, and is not related to any existing directors.

Camlin Fine Sciences Ltd share price declined by 1.66% to Rs 124.35 after the company's net profit witnessed a sharp fall of 138.97% to Rs 33.62 crore, while revenue from operations increased sharply by 22.38% to Rs 519.88 crore in Q2FY26 over Q1FY26. The market capitalization of Specialty Chemicals industry group stocks on BSE stood at Rs 5.09 lakh crore, rallying 15.27%. It has marginally improved by 1.74% over last one week and moving up by 12.24% in last one month while the market capitalization of Camlin Fine Sciences Ltd has eased by 4.75% and 4.63% in the same period respectively. Profit before tax (PBT) of Camlin Fine Sciences Ltd stood at Rs 34.09 crore in Q2 FY26, surging by 218.30% year-on-year, and plunging by 142.59% quarter-on-quarter. EBITDA came in at Rs 8 crore, tanking 41.87% YoY and nosediving by 391.91% sequentially. Total expenses surged 24.81% to Rs 529.76 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 312.35 crore, soaring by 158.72% YoY, while employee benefits expense was at Rs 73.43 crore, rising by 11.38% YoY. For the TTM ended FY26, revenue from operations tick up 5.81% to Rs 1723.31 crore, while net profit tumbled by 148.44% to Rs 31.53 crore, compared to previous TTM. EBITDA soared by 20985% to Rs 78.09 crore, and PBT plunged by 149.54% to Rs 31.99 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 82.07 crore in FY26, as against Rs 23.0 crore in FY25. Camlin Fine Sciences Ltd crashed 44.31% in last one year, underperforming the benchmark BSE Sensex which has eased by 2.56% during the same period.

Camlin Fine Sciences Limited will hold a board meeting on August 11, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, according to a regulatory filing. The company previously closed the trading window for its equity shares from July 1, 2026, until 48 hours after the financial results are made public.

Camlin Fine Sciences announced that the 33th Annual General Meeting(AGM) of the company will be held on 11 August 2026.

Net profit of Camlin Fine Sciences reported to Rs 88.20 crore in the quarter ended March 2026 as against net loss of Rs 0.72 crore during the previous quarter ended March 2025. Sales declined 1.57% to Rs 424.81 crore in the quarter ended March 2026 as against Rs 431.58 crore during the previous quarter ended March 2025. For the full year,net profit reported to Rs 27.63 crore in the year ended March 2026 as against net loss of Rs 139.05 crore during the previous year ended March 2025. Sales rose 5.81% to Rs 1723.31 crore in the year ended March 2026 as against Rs 1628.69 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales424.81431.58 -2 1723.311628.69 6 OPM %4.9914.38 -6.2013.26 - PBDT23.5160.10 -61 64.40135.35 -52 PBT2.6942.95 -94 -6.5274.39 PL NP88.20-0.72 LP 27.63-139.05 LP Powered by Capital Market - Live

The board of Camlin Fine Sciences at its meeting held on 26 May 2026 has approved the appointment of Pankaj Pandey as Chief Financial Officer (CFO) and Key Managerial Personnel of the Company, effective 18 August 2026. Further, the board approved the re-designation of Santosh Parab, currently Chief Financial Officer, as President - Strategy and Global CFO, effective 18 August 2026.

Camlin Fine Sciences will hold a meeting of the Board of Directors of the Company on 26 May 2026.

Le Travenues Technology Ltd, CCL Products (India) Ltd, Vishal Mega Mart Ltd and Kesoram Industries Ltd are among the other losers in the BSE's 'A' group today, 09 April 2026.Camlin Fine Sciences Ltd crashed 5.32% to Rs 103.68 at 14:44 IST.The stock was the biggest loser in the BSE's 'A' group.On the BSE, 78187 shares were traded on the counter so far as against the average daily volumes of 98653 shares in the past one month.Le Travenues Technology Ltd tumbled 5.31% to Rs 169.45. The stock was the second biggest loser in 'A' group.On the BSE, 1.03 lakh shares were traded on the counter so far as against the average daily volumes of 99518 shares in the past one month.CCL Products (India) Ltd lost 4.66% to Rs 1071. The stock was the third biggest loser in 'A' group.On the BSE, 74026 shares were traded on the counter so far as against the average daily volumes of 34630 shares in the past one month.Vishal Mega Mart Ltd shed 4.63% to Rs 111.2. The stock was the fourth biggest loser in 'A' group.On the BSE, 5.89 lakh shares were traded on the counter so far as against the average daily volumes of 12.09 lakh shares in the past one month.Kesoram Industries Ltd slipped 4.05% to Rs 10.89. The stock was the fifth biggest loser in 'A' group.On the BSE, 9 lakh shares were traded on the counter so far as against the average daily volumes of 1.83 lakh shares in the past one month.